The Effects of Whole Food Intervention on Mucositis in Patients Treated for Head and Neck Cancer

October 9, 2015 updated by: Providence Health & Services

The Effects of Whole Food Intervention on Mucositis in Patients Being Treated for Head and Neck Cancer With Radiation With or Without Chemotherapy

This is a study to see if a Whole Food Intervention (WFI) consisting of yogurt, butter, honey, vanilla, and glutamine will lower the frequency or severity of mucositis in head and neck cancer patients undergoing standard treatment.

Study Overview

Status

Terminated

Conditions

Detailed Description

The proposal is a one center, open label, randomized pilot study to evaluate the safety, tolerability and compliance of a Whole Food Intervention with Standard of Care for patients with head & neck cancer. The primary objectives are:

  1. To determine whether patients will use a Whole Food Intervention 4-6 times daily, and
  2. To determine whether the Whole Food Intervention will reduce the incidence of grade 2 or greater mucositis from 75% historically seen to 25% .
  3. To determine whether Whole Food Intervention will reduce the incidence of treatment breaks from >19% to < 10% (see section 9 for comments)

This Whole Food Intervention will be taken by mouth before the start of radiation therapy, with or without chemotherapy and for the entire treatment therapy.

Mucositis-related pain and reduction of oral intake will be quantified by using validated assessment tools. Weight loss or gain, diarrhea, constipation or no change in bowel function and the use of conventional medication for radiation-induced mucositis will be recorded. Chart review and patient questionnaires will be used to establish whether a treatment break or dose reduction for radiation of chemotherapy was required due to radiation mucositis-related symptoms. Complete Chemistry Profile and Complete Blood Count will be extracted from the patients' medical oncologist's or radiation oncologist's records. The patient will continue to use standard mucositis therapies if desired as prescribed by the treating oncology physician.

The Whole Food Intervention consists of yogurt, butter, honey, vanilla, and glutamine with 3 portioning cups, equal to approximately 12 ounces, taken daily before starting radiation therapy. A questionnaire will be used to record symptoms and doses taken. The patient will continue to use standard mucositis therapies as prescribed by the treating oncology physician.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oregon
      • Portland, Oregon, United States, 97213
        • The Oregon Clinic, Providence Portland Cancer Center
      • Portland, Oregon, United States, 97225
        • Integrative Medicine Program, Providence St. Vincent Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Histopathologically confirmed diagnosis of head & neck carcinoma
  • Scheduled to undergo continuous daily course of radiation therapy with or without chemotherapy
  • No other serious concurrent medical illness as determined by the Principle Investigator
  • Absolute neutrophil count ≥ 500/mm3
  • Platelet count ≥ 50,000/mm3
  • No history of insulin-dependent diabetes mellitus
  • No prior hypersensitivity reaction to compound components

Exclusion Criteria:

  • Dislike of the available forms of the WFI
  • Allergy or food intolerance relevant to the ingredients
  • Lack of access to refrigerated storage for the WFI
  • Inability or unwillingness to participate twice a week
  • Inability to swallow
  • Undergoing treatment for HIV with HIV medications
  • Ongoing alcohol and/or drug abuse

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Whole Food Intervention Treated
Group of participants given the experimental WFI along with standard cancer treatment.
A combination of honey, glutamine, probiotics, and butter was administered to participants undergoing cancer.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of Tolerability
Time Frame: Eight (8) weeks
Estimated portion consumption on a daily basis was obtained to determine if the WFI could be tolerated by participants.
Eight (8) weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment Break Measurement
Time Frame: Eight (8) weeks
To determine whether Whole Food Intervention will reduce the incidence of treatment breaks from ≥19% to ≤10%.
Eight (8) weeks
Mucositis Grading
Time Frame: Eight (8) weeks
Mucositis grade was calculated using established criteria.
Eight (8) weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Miles H Hassell, MD, Providence Health & Services

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2009

Primary Completion (Actual)

September 1, 2012

Study Completion (Actual)

September 1, 2012

Study Registration Dates

First Submitted

September 25, 2015

First Submitted That Met QC Criteria

October 9, 2015

First Posted (Estimate)

October 14, 2015

Study Record Updates

Last Update Posted (Estimate)

October 14, 2015

Last Update Submitted That Met QC Criteria

October 9, 2015

Last Verified

October 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mucositis

Clinical Trials on Whole Food Intervention

3
Subscribe